1

MAIA Biotechnology

#9793

Rank

$46.77M

Marketcap

US United States

Country

MAIA Biotechnology
Leadership team

Dr. Mihail Obrocea M.D. (Chief Medical Officer & Head of Devel.)

Dr. Vlad Vitoc M.B.A., M.D. (Co-Founder, Pres, CEO & Chairman of Directors)

Mr. Joseph F. McGuire (Chief Financial Officer)

Products/ Services
Biotechnology
Headquarters
Chicago, Illinois, United States
Established
2018
Company Registration
SEC CIK number: 0001878313
Traded as
MAIA
Overview
Location
Summary
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.
History

MAIA Biotechnology was founded in 2017 with a focus on the development of therapies to extend the healthspan of individuals through personalized medicines and diagnostics. Over the past three years, MAIA has grown and advanced its foundation research, expanding a pipeline of novel therapeutics for age-related and unmet medical needs.

Mission
MAIA’s mission is to improve the quality of life for all individuals through age-related disease diagnostics and therapies.
Vision
MAIA’s vision is to lead an industry-wide shift towards personalized medicine that is driven by the convergence of omics, biomarkers and informatics.
Key Team

Dr. Sergei M. Gryaznov Ph.D. (Chief Scientific Officer)

Linda Moreira (Company Sec.)

Recognition and Awards
MAIA has been recognized with numerous awards and recognitions over the past few years, including the Forbes 30 Under 30 and the 2019 Top Human and Machine Intelligence Award from Modern Medicine.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

MAIA Biotechnology
Leadership team

Dr. Mihail Obrocea M.D. (Chief Medical Officer & Head of Devel.)

Dr. Vlad Vitoc M.B.A., M.D. (Co-Founder, Pres, CEO & Chairman of Directors)

Mr. Joseph F. McGuire (Chief Financial Officer)

Products/ Services
Biotechnology
Headquarters
Chicago, Illinois, United States
Established
2018
Company Registration
SEC CIK number: 0001878313
Traded as
MAIA